You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CATX Sale Disclosure
Lantheus Alpha Therapy, Llc · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$245.61K
Lantheus Alpha Therapy, Llc 10% owner
CATX
Transaction date
Aug 31, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 4 days later
CATX daily price context
Close on/before transaction
$3.16
Aug 31, 2026
First close after public filing
$3.12
Sep 8, 2026
30-day return after filing
-17.63%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 78,145 shares @ $3.14
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002064832-26-000314
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$357.18K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Perspective Therapeutics, Inc. CATX | Sale | Sep 1, 2026 | $111.57K |
| Perspective Therapeutics, Inc. CATX Current | Sale | Aug 31, 2026 | $245.61K |